| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.85 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.4 | 0.05 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.33 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.3 | 0.04 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.1 |